Development Strategy for Early-Stage Assets: The Commercial-Clinical Handshake

Life Sciences, Commercialization & HEOR,
  • Tuesday, March 19, 2024

Product development from translation to registration has become increasingly more difficult and costly. Ambitions are high but success rates are low. If development is a tough path, commercialization is even harder. In 2022, the average year-one sales per branded product were a mere $65M. In 2021, 45% of all prescriptions were rejected or blocked. To realize an asset’s full potential and differentiate it from the competition, it takes a strategy built with a multi-disciplinary approach that recognizes the needs of patients, healthcare practitioners and payers early in the development process.

This webinar will discuss the importance of incorporating the commercial voice early in the development process. It will focus on the need to create a handshake between commercial and clinical on the key attributes of an asset, the importance of developing a meaningful target product profile (TPP) and the evolving nature of the commercial landscape.

Register for this webinar today to gain insights into the importance of developing a meaningful target product profile and incorporating the commercial voice early in development.


William Bainbridge, Premier Consulting

William Bainbridge, Senior Director, Commercial Strategy, Premier Consulting

Will Bainbridge, Sr. Director, Commercial Strategy Solutions, leads commercial strategy at Premier Consulting. He has over 20 years of leadership experience in the Pharmaceutical, Biotech, MedTech and Consulting industries across multiple therapeutic areas, business models and companies, including Novo Nordisk and GSK. He has held US and global strategic leadership positions with full P&L responsibility. Will has extensive experience in business development, strategic planning, portfolio strategy and new product planning for small- to mid-size Biotech companies and Big Pharma. It spans the entire clinical development journey. His combined operating and advisory experience enable him to provide firsthand client focus, define risk, create opportunity and develop practical solutions to address complex business needs.

Message Presenter

Who Should Attend?

This webinar will benefit managers and others in leadership roles at biotech and specialty pharma companies with job functions including, but not limited, to:

  • Commercial strategy
  • Regulatory affairs
  • Business development
  • Project management

What You Will Learn

Topics will include:

  • Product development strategy should start with the end in mind
  • The importance of incorporating patient, healthcare practitioner and payer needs early in the development process. One customer is not more important than the other.
  • Target product profile development is a multi-disciplinary team sport

Xtalks Partner

Premier Consulting

Premier Consulting is a strategic product development and global regulatory consulting company dedicated to helping biotech innovators transform their life-changing ideas and breakthrough science into new medical treatments. Our end-to-end solutions in strategy, regulatory, nonclinical, CMC, quality, and commercial help sponsors build and execute development plans that meet regulatory requirements and deliver results for sponsors and the patients they serve.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account